The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of body mass index on the prognosis of Japanese women with operable hormone receptor-positive breast cancer: A single institutional retrospective study.
 
Jun Masuda
Honoraria - Toray Industries
 
Yukinori Ozaki
Honoraria - Chugai Pharma
 
Akemi Kataoka
No Relationships to Disclose
 
TAKAHIRO KOGAWA
Research Funding - Lilly (Inst)
 
Natsue Uehiro
No Relationships to Disclose
 
Lina Inagaki
No Relationships to Disclose
 
Tomomi Abe
No Relationships to Disclose
 
Yurie Haruyama
No Relationships to Disclose
 
Saori Kawai
No Relationships to Disclose
 
Fumikata Hara
Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Lilly Japan; Novartis; Pfizer; Taiho Pharmaceutical
 
Hidetomo Morizono
No Relationships to Disclose
 
Toshimi Takano
Honoraria - Celltrion; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Lilly; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Kyowa Kirin (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Takayuki Ueno
Honoraria - AstraZeneca Japan; Chugai Pharma; Eisai; Novartis; Pfizer; Taiho Pharmaceutical
Consulting or Advisory Role - Pfizer
Research Funding - Eisai
 
Shinji Ohno
Speakers' Bureau - AstraZeneca; Chugai Pharma; Eisai; Lilly; Pfizer
Research Funding - Eisai (Inst)